EMMA RAGAN: Open Payments
NPI 1194305037 · CENTENNIAL, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$878 in 38 payments from 13 companies in 2025. Trend: 2023 $553 · 2024 $561 · 2025 $878
Food & beverage: $773Consulting: $105
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $330 |
| AstraZeneca Pharmaceuticals LP | 3 | $153 |
| Eisai Inc. | 1 | $105 |
| PFIZER INC. | 3 | $59 |
| Exact Sciences Corporation | 3 | $46 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $38 |
| Amgen Inc. | 2 | $31 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Novo Nordisk Inc | 1 | $27 |
| Seqirus USA Inc | 1 | $18 |
Products named: QULIPTA, UBRELVY, FARXIGA, Leqembi, NURTEC ODT, Cologuard Collection Kit, JOURNAVX, SHINGRIX.
Industry payments across CO — which companies pay providers there.
